1 |
Fleischmann M, Mandal R, Kostova I, Raab M, Sanhaji M, Hehlgans S, Diefenhardt M, Rödel C, Fokas E, Strebhardt K, Rödel F. Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy. Cancers (Basel) 2022;14. [PMID: 36428594 DOI: 10.3390/cancers14225500] [Reference Citation Analysis]
|
2 |
Wu YC, Chen CH, Ko YL, Yuan CC, Wang PH, Chu WC. Classification of Vascular Hotspots and Micro-Vessel Flow Velocity Waveforms in Low-Grade Squamous Intraepithelial Lesions and HPV Condyloma of the Cervix. Diagnostics (Basel) 2022;12. [PMID: 36292079 DOI: 10.3390/diagnostics12102390] [Reference Citation Analysis]
|
3 |
Evans AM, Salnikov M, Gameiro SF, Maleki Vareki S, Mymryk JS. HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct. JCM 2022;11:4825. [DOI: 10.3390/jcm11164825] [Reference Citation Analysis]
|
4 |
Xiang N, Chen T, Zhao X, Zhao M. In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer. Tissue and Cell 2022;77:101845. [DOI: 10.1016/j.tice.2022.101845] [Reference Citation Analysis]
|
5 |
Jin J, Du X, Zhou L, Yao D, Zou Q. SPI1-related protein inhibits cervical cancer cell progression and prevents macrophage cell migration. J Obstet Gynaecol Res 2022. [PMID: 35770729 DOI: 10.1111/jog.15336] [Reference Citation Analysis]
|
6 |
Bukkems LJ, Jürgenliemk-schulz IM, van der Leij F, Peters M, Gerestein CG, Zweemer RP, van Rossum PS. The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: a systematic review and meta-analysis. Clinical and Translational Radiation Oncology 2022. [DOI: 10.1016/j.ctro.2022.05.006] [Reference Citation Analysis]
|